Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
Search results for: pain
Drug Diversion Concerns on the Rise
Medications removed from legitimate supply channels can affect both physician and patient.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
AMA House of Delegates Meeting: Decisions Affecting You
An overview of some of the issues that were covered during the June 2012 American Medical Association House of Delegates meeting to debate policy.
Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting
The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.
Coding Corner Question: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
- « Previous Page
- 1
- …
- 188
- 189
- 190
- 191
- 192
- …
- 231
- Next Page »